Stay updated on Pembrolizumab SBRT in TKI mRCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab SBRT in TKI mRCC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The Locations section was updated to add Alberta and Ontario locations and remove the former Alberta Locations and Ontario Locations entries, with the revision updated to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T07:58:01.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:49:17.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.2.0 to v3.3.1; no other visible content changes.
    Difference
    0.1%
    Check dated 2025-11-24T13:43:03.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The page no longer displays the government funding status notice that previously appeared at the top. All study details, eligibility criteria, and contact information remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:29:09.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The new screenshot shows only minor visual/layout adjustments with no changes to core study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:12:43.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    Summary: The page now displays a funding-status notice impacting operations and announces a new software version v3.2.0, replacing v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T10:11:47.000Z thumbnail image

Stay in the know with updates to Pembrolizumab SBRT in TKI mRCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.